Literature DB >> 19022405

Heart rate, lifespan, and mortality risk.

Gus Q Zhang1, Weiguo Zhang.   

Abstract

An increasing body of scientific research and observational evidence indicates that resting heart rate (HR) is inversely related to the lifespan among homeothermic mammals and within individual species. In numerous human studies with patients stratified by resting HR, increased HR is universally associated with greater risk of death. The correlation between HR and maximum lifespan seems to be due to both basal metabolic rate and cardiovascular-related mortality risk. Both intrinsic and extrinsic factors are already postulated to determine how the biological clock works, through regulating and modulating the processes such as protein oxidation, free radical production, inflammation and telomere shortening. Given the remarkable correlation between HR and lifespan, resting HR should be seriously considered as another possible cap on maximum lifespan. Future research is needed to determine whether deliberate cardiac slowing, through methods like lifestyle modification, pharmacological intervention, or medical devices, can decelerate biological clock of aging, reduce cardiovascular mortality and increase maximum lifespan in humans in general.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022405     DOI: 10.1016/j.arr.2008.10.001

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  28 in total

Review 1.  Applied Healthspan engineering.

Authors:  James W Larrick; Andrew Mendelsohn
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

2.  Testing an association between baseline resting pulse rate averages and short-term changes in resting pulse rates: A pilot study.

Authors:  John Hart
Journal:  J Can Chiropr Assoc       Date:  2015-06

3.  Getting to the heart of the matter: age-related changes in diastolic heart function in the longest-lived rodent, the naked mole rat.

Authors:  Kelly M Grimes; Merry L Lindsey; Jonathan A L Gelfond; Rochelle Buffenstein
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-02-24       Impact factor: 6.053

Review 4.  Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Authors:  Jochen Antel; Özgür Albayrak; Gerd Heusch; Tobias Banaschewski; Johannes Hebebrand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-23       Impact factor: 5.270

5.  Effect of soybean oil on atherogenic metabolic risks associated with estrogen deficiency in ovariectomized rats: dietary soybean oil modulate atherogenic risks in overiectomized rats.

Authors:  Hanaa A Hassan; Mosaad A Abdel-Wahhab
Journal:  J Physiol Biochem       Date:  2011-12-29       Impact factor: 4.158

Review 6.  Novel drugs for heart rate control in heart failure.

Authors:  Agata Bielecka-Dabrowa; Stephan von Haehling; Jacek Rysz; Maciej Banach
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

Review 7.  The vertebrate heart: an evolutionary perspective.

Authors:  Andrea Stephenson; Justin W Adams; Mauro Vaccarezza
Journal:  J Anat       Date:  2017-09-14       Impact factor: 2.610

Review 8.  ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.

Authors:  Dimitry A Chistiakov; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Lab Invest       Date:  2016-05-16       Impact factor: 5.662

9.  Nonpharmacological Correction of Hypersympatheticotonia in Patients with Chronic Coronary Insufficiency and Severe Left Ventricular Dysfunction.

Authors:  Sergey A Afanasiev; Elena N Pavliukova; Maria A Kuzmichkina; Tatiana Yu Rebrova; Yana Anfinogenova; Konstantin S Likhomanov; Rostislav S Karpov
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-07       Impact factor: 1.468

10.  Human heart rate: heritability of resting and stress values in twin pairs, and influence of genetic variation in the adrenergic pathway at a microribonucleic acid (microrna) motif in the 3'-UTR of cytochrome b561 [corrected].

Authors:  Kuixing Zhang; Dekker C Deacon; Fangwen Rao; Andrew J Schork; Maple M Fung; Jill Waalen; Nicholas J Schork; Caroline M Nievergelt; Neil C Chi; Daniel T O'Connor
Journal:  J Am Coll Cardiol       Date:  2013-10-16       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.